Загрузка...
Drugging in the absence of p53
Inactivation of the p53 gene is a key driver of tumorigenesis in various cancer cohorts and types. The quest for a successful p53-based therapy that holds the promise of treating more than half of the cancer population has culminated in extensive knowledge about the role and function of p53 and led...
Сохранить в:
| Опубликовано в: : | J Mol Cell Biol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478123/ https://ncbi.nlm.nih.gov/pubmed/30865230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjz012 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|